LEMAITRE VASCULAR, INC. Net Income (Loss) Available to Common Stockholders, Diluted
LEMAITRE VASCULAR, INC. (LMAT) reported Net Income (Loss) Available to Common Stockholders, Diluted of $18.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was $18.05M, a 31.00% increase year-over-year.
- LEMAITRE VASCULAR, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $18.36M, a 64.81% increase year-over-year.
- LEMAITRE VASCULAR, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-06-30 was $13.78M.
- LEMAITRE VASCULAR, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2024-09-30 was $11.14M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|
| 2026-06-30 | $18.05M 10-Q · filed 2026-08-05 | $34.76M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $18.36M 10-Q · filed 2025-11-07 | $32.14M derived: sum of 2 quarters · filed 2026-08-05 | $42.15M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $13.78M 10-Q · filed 2026-08-05 | $24.79M 10-Q · filed 2026-08-05 | |
| 2024-09-30 | $11.14M 10-Q · filed 2025-11-07 | $32.85M 10-Q · filed 2025-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |